News-Medical.Net on MSN

PSA-based tool improves decision making for prostate cancer screening and treatment

In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...

Letters to the Editor: Early detection is one of the best weapons we have in fighting cancer

I was fortunate to have my prostate cancer detected in 2017 before it was too late to treat and today, I'm cancer-free,' ...

Clinical Trial Targets Recurrent Prostate Cancer

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...

New model improves prediction of prostate cancer death risk

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...
European Medical Journal

PSA Derivatives to Reduce Unnecessary Prostate MRI

Can PSA derivatives reduce unnecessary prostate MRI after negative biopsy? Learn how simple markers may guide imaging ...
EurekAlert!

HKUMed study confirms high cost-effectiveness of prostate cancer screening, advocating for ...

A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of ...

Predicting prostate cancer recurrence through power of AI

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Bi opsy of the P rostate A voidance S ...